Rakuten Securities Inc. Purchases New Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Rakuten Securities Inc. bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) during the fourth quarter, HoldingsChannel.com reports. The fund bought 185 shares of the biotechnology company’s stock, valued at approximately $48,000.

A number of other institutional investors have also recently added to or reduced their stakes in AXON. Westfield Capital Management Co. LP lifted its stake in shares of Axon Enterprise by 184.3% during the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after purchasing an additional 451,350 shares in the last quarter. Vaughan Nelson Investment Management L.P. lifted its position in Axon Enterprise by 18.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock worth $27,019,000 after acquiring an additional 16,230 shares in the last quarter. BKM Wealth Management LLC purchased a new position in Axon Enterprise in the 4th quarter worth approximately $32,000. Sumitomo Mitsui Trust Holdings Inc. grew its position in Axon Enterprise by 0.3% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock valued at $29,320,000 after acquiring an additional 495 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $39,907,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Trading Down 0.2 %

Shares of Axon Enterprise stock opened at $299.82 on Thursday. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The company’s fifty day moving average price is $299.84 and its two-hundred day moving average price is $257.02. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The firm has a market capitalization of $22.62 billion, a PE ratio of 130.36 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. On average, analysts expect that Axon Enterprise, Inc. will post 2.43 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Robert W. Baird lifted their price target on shares of Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. Needham & Company LLC raised their price objective on Axon Enterprise from $315.00 to $400.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. Argus initiated coverage on shares of Axon Enterprise in a research note on Wednesday, March 13th. They set a “buy” rating and a $380.00 target price for the company. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Finally, Barclays boosted their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $312.64.

View Our Latest Report on Axon Enterprise

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.